• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page


Beigene





The job in the southeast was just filled without being posted. This is so old white boys club. If you are a white guy who worked at celgene you can have the job handed to you? Where are the HR department rules? AS what is wrong with you? You should know better.

They are shouting we promote from within but its not open, fair, or transparent.
 




































how about in new england? heard many reps left already

See previous posts. Micromanager in NE. Three reps have left her team. 1 other on another team left oncology period and early on. No other departures in commercial, except DM that took NSD role.

There are probably a few unhappy people due to lack of performance (0-1 patients total since launch). They still have made excellent bonuses thanks to a generous national plan. Everybody else is happy with the culture, performance, and equity offerings. Stock is way up since many of us joined and vested shares are worth $$$.
 




See previous posts. Micromanager in NE. Three reps have left her team. 1 other on another team left oncology period and early on. No other departures in commercial, except DM that took NSD role.

There are probably a few unhappy people due to lack of performance (0-1 patients total since launch). They still have made excellent bonuses thanks to a generous national plan. Everybody else is happy with the culture, performance, and equity offerings. Stock is way up since many of us joined and vested shares are worth $$$.

Good to see management trolling the site. No rep has vested shares.